1.750USD+5.05%Mkt Cap: 7.94M USDP/E: —Last update: 2026-06-01
bioAffinity Technologies, Inc. engages in developing non-invasive diagnostic laboratory tests to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis in the United Sta…
Industry Peers
Diagnostics & Research183.26BUSDP/E 27.1
127.46BUSDP/E 35.0
45.09BUSDP/E 42.1
38.48BUSDP/E 27.4
37.00BUSDP/E 47.9
34.66BCHFP/E 38.1
31.51BUSD—
31.45BUSDP/E 23.4
Indicators:|
Key Statistics
Company
Market Cap7.94M USD
Enterprise Value5.79M USD
Revenue (TTM)5.66M USD
Gross Profit1.88M USD
Net Income (TTM)-14.91M USD
Revenue/Share2.089 USD
Last Price1.750 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees57
CountryUS
SectorHealthcare
IndustryDiagnostics & Research
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-2.78
PEG—
EV/EBITDA-0.53
EV/Revenue1.02
P/S1.34
P/B2.05
EPS (TTM)-4.67
EPS (Forward)-0.60
52W Range
0.69308% of range13.80
52W High13.80 USD
52W Low0.6930 USD
Profitability
Gross Margin30.80%
Oper. Margin-267.62%
EBITDA Margin-194.17%
Profit Margin-244.10%
ROE-204.87%
ROA-136.03%
Growth
Revenue Growth-27.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF-9.33M USD
CapEx (TTM)60.57K USD
FCF Margin—
FCF Yield—
Net Debt-1.72M USD
Net Debt/EBITDA0.16
Balance Sheet
Debt/Equity0.16
Current Ratio1.36
Quick Ratio1.19
Book Value/Sh0.8150 USD
Cash/Share0.6890 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:30
Split DateSep 19, 2025
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.4.53M
Float4.39M
Insiders3.24%
Institutions9.06%
Short Interest
Short Ratio1.4d
Short % Float11.11%
Short % Out.10.89%
Shares Short494.01K
Short (prev mo.)515.76K
Technical
SMA 502.713 (-35.5%)
SMA 2002.806 (-37.6%)
Beta-1.19
S&P 52W Chg27.94%
Avg Vol (30d)297.58K
Avg Vol (10d)150.44K
Technical Indicators
RSI (14)38.0
MACD-0.2400
MACD Signal-0.2525
MACD Hist.+0.0125
BB Upper2.257 USD
BB Middle1.849 USD
BB Lower1.440 USD
BB Width44.17%
ATR (14)0.2256 USD
Vol Ratio (20d)0.31x